Simon STAMM

Person

Allschwil, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Indole carboxamide derivatives as P2X7 receptor antagonist
- Patent number 9,718,774
- Issue date Aug 1, 2017
- IDORSIA PHARMACEUTICALS LTD
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole carboxamide derivatives as P2X7 receptor antagonists
- Patent number 9,556,117
- Issue date Jan 31, 2017
- Actelion Pharmaceuticals Ltd.
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic amide derivatives as P2X7 receptor antagonists
- Patent number 9,409,917
- Issue date Aug 9, 2016
- Actelion Pharmaceuticals Ltd.
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic amide derivatives as P2X7 receptor antagonists
- Patent number 9,388,197
- Issue date Jul 12, 2016
- Actelion Pharmaceuticals Ltd.
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic amide derivatives as P2X7 receptor antagonists
- Patent number 9,388,198
- Issue date Jul 12, 2016
- Actelion Pharmaceuticals Ltd.
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic amide derivatives as P2X7 receptor antagonists
- Patent number 9,221,832
- Issue date Dec 29, 2015
- Actelion Pharmaceuticals Ltd.
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS
- Publication number 20180230109
- Publication date Aug 16, 2018
- Actelion Pharmaceuticals LTD
- Olivier BEZENCON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS
- Publication number 20170096399
- Publication date Apr 6, 2017
- Actelion Pharmaceuticals LTD
- Romain SIEGRIST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- Publication number 20150361096
- Publication date Dec 17, 2015
- Actelion Pharmaceutical Ltd.
- KURT HILPERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- Publication number 20150361097
- Publication date Dec 17, 2015
- Actelion Pharmaceuticals LTD
- KURT HILPERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- Publication number 20150344425
- Publication date Dec 3, 2015
- Actelion Pharmaceuticals LTD
- KURT HILPERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONIST
- Publication number 20150322008
- Publication date Nov 12, 2015
- Actelion Pharmaceuticals LTD
- KURT HILPERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- Publication number 20150025075
- Publication date Jan 22, 2015
- Actelion Pharmaceuticals LTD
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- Publication number 20140163035
- Publication date Jun 12, 2014
- Actelion Pharmaceuticals LTD
- Kurt Hilpert
- C07 - ORGANIC CHEMISTRY

Simon STAMM

Person

Patents Grantslast 30 patents

Indole carboxamide derivatives as P2X7 receptor antagonist

Indole carboxamide derivatives as P2X7 receptor antagonists

Heterocyclic amide derivatives as P2X7 receptor antagonists

Heterocyclic amide derivatives as P2X7 receptor antagonists

Heterocyclic amide derivatives as P2X7 receptor antagonists

Heterocyclic amide derivatives as P2X7 receptor antagonists

Patents Applicationslast 30 patents

TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS

PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONIST

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS